Navigation Links
Centrillion Biosciences Announces Winners of Next-gen Sequencing Innovation Grant Program
Date:7/19/2013

Palo Alto, CA (PRWEB) July 19, 2013

Two winning teams were chosen; Ryan Hernandez and Nicolas Strauli won for their proposal, “Intra-patient coevolution between HIV and the adaptive immune system.” Dr. Hernandez is an Assistant Professor in the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco. Nicolas Strauli is a graduate student working with Dr. Hernandez. Jianzhong Hu won for his proposal, “Association of Meconium Microbiome to Preterm Birth and Maternal Environment”. Dr. Hu is an Assistant Professor in the Department of Genetics and Genomic Sciences at Mount Sinai Medical Center in New York City, NY.

About the award, Dr. Hernandez said: "This award will enable us to create a remarkable dataset that will yield insights into the problem of HIV's evasion of the adaptive immune system. By using next-generation sequencing, we have the potential to detail all of the steps taken by HIV and our immune system during the evolutionary dance that they play over the course of long-term infections. “

About the impact this award will have on his work, Dr. Hu said, “…this award will allow us to determine the role of the microbiome in preterm birth. By also assessing the interaction between the microbiome and clinical and environmental factors, we may begin to detect microbial predictors affecting health in later childhood development.”

The awards include sample sequencing and bioinformatics analysis services.

"We were extremely pleased with the quality of proposals for applications of next-gen sequencing and genomics to important problems in human health,” said Wei Zhou, Centrillion’s President and CEO. “Choosing the winners was a difficult decision and we wish we could support all of the research proposals.”

Full details may be found on the Centrillion web site: http://www.centrillionbio.com

About Centrillion Biosciences Inc.
Centrillion Biosciences is a leading genomic and bioinformatics solution provider. Our genomic technology dramatically improves sequencing performance and is compatible with leading genomic technology platforms. With the highest customer return and referral rate, our genomic and bioinformatics services utilize leading technologies and beyond to deliver the highest quality data in the fastest sample to result time. Our world class genomic technology development expertise enables our customers to succeed in the most challenging genomic research projects.

Media Contacts
Public Relations
Centrillion Biosciences, Inc.
2438 Embarcadero Way
Palo Alto, CA 94303
(650) 318-6235
pr(at)centrillionbio(dot)com

Read the full story at http://www.prweb.com/releases/2013/7/prweb10940302.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Centrillion Biosciences Announces Next-Gen Sequencing Innovation Grant Program
2. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2013 Financial Results
3. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
4. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
5. Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit
6. IntelliCell BioSciences Receives US Patent for its Stem Cell Extraction Technology
7. MEI Pharma Adds Former YM BioSciences CEO Nick Glover To Board Of Directors
8. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
9. Sangamo BioSciences Announces Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference
10. Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference
11. Provitro Biosciences Awarded First-Ever U.S. Patent For Large-Scale Production Of Bamboo Plants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of Commerce Penny Pritzker ... Biopharmaceuticals (NIIMBL), and the Department of Defense has announced the award of a ...
(Date:1/18/2017)... ... ... from a new study are stating that if levels of the blood test called ... there is still remaining prostate cancer cells that are more likely to come back, spreading ... an indicator of whether a man’s prostate cancer is growing or not,” stated Dr. ...
(Date:1/18/2017)... ... 18, 2017 , ... BidMed, LLC, announced it will hold a ... lab equipment from two different leading institutes. This highly specialized laboratory equipment is coming ... States. This 1-day online auction will take place on BidMed’s website http://www.bidmed.com ...
(Date:1/18/2017)... ... , ... Thirty-six startup companies in University City and Center City have been ... Economic Development in 2016 as part of the Keystone Innovation Zone (KIZ) Tax Credit ... and represent the highest number of awards to the largest number of companies in ...
Breaking Biology Technology:
(Date:1/11/2017)... Iowa , Jan. 11, 2017 Intoxalock, ... first with the release of its patent-pending calibration device. ... and reliably perform calibrations, securely upload data logs and ... for the customer. "Fighting drunk driving through ... for the public at large, but also for the ...
(Date:1/6/2017)... Jan. 6, 2017  Privately-held CalciMedica, Inc., announced ... healthy volunteers of a novel calcium release-activated calcium ... pancreatitis. Acute pancreatitis, sudden painful ... disorder, but can be very serious.  In severe cases ... where extended hospital stays, time in the ICU ...
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CES® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
Breaking Biology News(10 mins):